Article Text

Download PDFPDF
Idiopathic myelofibrosis with disseminated hepatosplenic, mesenteric, renal and pulmonary extramedullary haematopoeisis, portal hypertension and tuberculosis: initial presentation and 2 years follow-up
  1. Ananya Panda1,
  2. Sheragaru Hanumanthappa Chandrashekhara2,
  3. Aruna Nambirajan3,
  4. Pravas Mishra4
  1. 1All India Institute of Medical Science, New Delhi, India
  2. 2Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India
  3. 3Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
  4. 4Department of Hematology, All India Institute of Medical Science, New Delhi, India
  1. Correspondence to Dr Sheragaru Hanumanthappa Chandrashekhara, drchandruaiims{at}


A 35-year-old man with a 12-year history of idiopathic myelofibrosis (IMF) presented in 2014 with fatigue and abdominal distension. CT scan revealed massive hepatosplenomegaly with focal splenic lesions, soft tissue around renal pelvis, mesenteric masses compressing bowel loops and perilymphatic nodules in lungs. There was portal hypertension, ascites, pleural effusion, bilateral psoas abscesses and necrotic retroperitoneal lymphadenopathy. MRI additionally revealed hypointense periportal infiltrative lesions in liver, not seen on CT scan. None of these lesions showed diffusion restriction. Biopsy from mesenteric masses revealed extramedullary haematopoeisis. Aspiration from psoas abscess confirmed tuberculosis. Follow-up after 6 weeks of ruxolitinib (JAK2 tyrosine kinase inhibitor) and 9 months of antitubercular therapy revealed resolution of psoas abscesses and lymph nodes. Mild reduction was noted in mesenteric masses and ascites while perirenal soft tissue had increased. Follow-up imaging after another 1 year of ruloxitinib showed new-onset bilateral paravertebral and presacral foci of extramedullary haematopoeisis.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors AP carried out the literature search and primarily wrote the manuscript. SHC supervised and edited the manuscript. AN gave input on pathology of the condition. PM also edited the manuscript, gave inputs from haematology and on patient management.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.